Navigation Links
VS II

ProductsVS II
Company Roche Diagnostics
Item VS II
Features VS II system automates those tasks required to generate secondary sample tubes: aliquoting, bar code labeling, sorting and serum tube archiving. It prepares up to 780 tubes per hour for the placement on laboratorys analytical workstations or for the archive. It can be used alone or in combination with other task targeted systems such as the PSD 1 system to provide a customized approach to pre- and post-analytical sample handling. Automates time-consuming sample aliquoting, and sorting. Sorts both primary and secondary tubes with positive sample identification. Decreases the number of sample transfers by sorting directly into Roche/Hitachi 5 position rack, Cobas Core and Cobas Integra racks. Ensures sample integrity with clot detection and low liquid level detection. Separates questionable samples to an exception rack to quickly identify problematic. Reduces the safety risks of handling biological specimens. Reduces the human error associated with manual sample processing and labeling. 1 aliquot per primary sample: up to 360 ps/h, 2 aliquots per primary sample: up to 260 ps/h, Sample sorting: up to 780 ps/hr.
Description The Roche Diagnostics Task Targeted Automation VS II is a state-of-the-art automation of pre- and post-analytical steps in the laboratories: decapping, sorting / archiving of primary tubes and aliquoting into bar code labeled secondary tubes. Fully scalable and extendable to future needs.
Info Roche DiagnosticsCall Roche Diagnostics to buy products (US and Canada only; other locations use number below) USACanada1-866-415-6694

Customer Service: 1-800-428-5074
Web site: http://www.roche-diagnostics.com

Related medicine products :

1. VS II Standalone
2. PDQ Standalone
The CSV-1000SLanC test face provides the same tests as the standard CSV-1000S, except that the acuity test is presented in Landolt C format. , ,This test is very useful when testing patients who cann...
... face is used widely for screening refractive ... acuity from 20/10 to 20/100 and one ... , ,The patient can be easily screened ... and contrast sensitivity. If a contrast sensitivity ...
The compact, simple-to-use ECG for medical professionals....
... is the latest addition to the RX ... is a compact, semi-automated clinical analyser for ... monza is a complete clinical analyser with ... for straightforward operation and consistent performance, the ...
Medicine Products:
(Date:5/27/2016)... ... May 27, 2016 , ... With ... pharmaceutical, medical and food industries. Aside from its GMP accreditation, Validation Center is ... of successfully certified products, services and staff. , Validation Center is ISO17025 accredited ...
(Date:5/26/2016)... Louis, Missouri (PRWEB) , ... May 26, 2016 ... ... cost, quality and clinical outcomes, hosted members and suppliers for its inaugural Member ... a focus on their mission of elevating the operational health of America’s healthcare ...
(Date:5/26/2016)... , ... May 26, 2016 , ... ... that has a significant negative impact on long-term patient survival, reports a team ... results, published online this week in the Journal of Thoracic and Cardiovascular Surgery, ...
(Date:5/26/2016)... ... , ... An April Gallup survey found rising health care costs to be ... Health Senior Living (SHSL) may not share those same worries thanks to a ... the year, while holding the line on increasing their contributions, including premiums, deductibles and ...
(Date:5/26/2016)... , ... May 26, 2016 , ... The Lung ... host a six-week smoking cessation class starting June 6 at their clinic in downtown ... http://www.gnahec.org . , Additionally, the Lung Institute has created a free downloadable 4 Week ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... , May 25, 2016 ... 2016"market research report that provides an overview on ... analysis at various stages, therapeutics assessment by drug ... (RoA) and molecule type, along with latest updates, ... reviews key players involved in the therapeutic development ...
(Date:5/24/2016)...   , Study met both ... superiority in , Excellent plus Good ... of the ascending colon   , ... today announced new positive data from the phase III MORA study ... 2 litre PEG with ascorbate. The study met both primary endpoints ...
(Date:5/24/2016)... , May 24, 2016 Celsion Corporation ... development company, today provided an update on its ... clinical trial combining GEN-1, the Company,s DNA-based immunotherapy, ... of newly-diagnosed patients with advanced ovarian cancer who ... surgery.  GEN-1 is an IL-12 DNA plasmid vector ...
Breaking Medicine Technology: